HeyJaredLisa Buckingham
- Indexed articles, last 90 days
- 65
- Latest publication
- Sep 30, 2026
- Outlet visibility, for FoodManufacture.co.uk
- Top 5M sites
- Earliest in this view
- Jul 8, 2026
Latest articles
92% want to eat better. Only 14% think they do (opens the original)
Read excerpt
There is often a gap between what consumers say they want and what they actually do, but a new retailer report discussed at Future Food-Tech London reveals a vast gulf when it comes to eating healthily. It found that while 92% of consumers want to change their diets to be healthier, these good intentions are not translating into healthier diets. Only 14% believe their diets are ‘very healthy’ and 23% are satisfied with their physical health. The report is from Ahold Delhaize, the parent company
92% want to eat better. Only 14% think they do (opens the original)
Read excerpt
There is often a gap between what consumers say they want and what they actually do, but a new retailer report discussed at Future Food-Tech London reveals a vast gulf when it comes to eating healthily. It found that while 92% of consumers want to change their diets to be healthier, these good intentions are not translating into healthier diets. Only 14% believe their diets are ‘very healthy’ and 23% are satisfied with their physical health. The report is from Ahold Delhaize, the parent company
GLP-1 creep: How weight-loss drugs are moving beyond their intended users (opens the original)
Read excerpt
A large new study has found an increase in the use of GLP-1s among people without apparent approved indications. Using the medical records of over 300 million people, it found that of 92,415,648 US adults without an apparent FDA-approved indication, 1,133,953 were prescribed GLP-1s. Notably, 35.1% had a normal BMI. And it’s on the rise. Between 2021 and 2025, prescriptions without an apparent indication increased from 0.11% to 1.5%, a 13.6-fold increase. A class pattern was also seen - use witho
GLP-1 creep: How weight-loss drugs are moving beyond their intended users (opens the original)
Read excerpt
A large new study has found an increase in the use of GLP-1s among people without apparent approved indications. Using the medical records of over 300 million people, it found that of 92,415,648 US adults without an apparent FDA-approved indication, 1,133,953 were prescribed GLP-1s. Notably, 35.1% had a normal BMI. And it’s on the rise. Between 2021 and 2025, prescriptions without an apparent indication increased from 0.11% to 1.5%, a 13.6-fold increase. A class pattern was also seen - use witho
GLP-1 creep: How weight-loss drugs are moving beyond their intended users (opens the original)
Read excerpt
A large new study has found an increase in the use of GLP-1s among people without apparent approved indications. Using the medical records of over 300 million people, it found that of 92,415,648 US adults without an apparent FDA-approved indication, 1,133,953 were prescribed GLP-1s. Notably, 35.1% had a normal BMI. And it’s on the rise. Between 2021 and 2025, prescriptions without an apparent indication increased from 0.11% to 1.5%, a 13.6-fold increase. A class pattern was also seen - use witho
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For FoodManufacture.co.uk, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.